메뉴 건너뛰기




Volumn 10, Issue 2, 2010, Pages 32-41

Investigation of the influence of tablet shape, geometry & film coating on drug release from hypromellose extended-release matrices

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE;

EID: 77949681147     PISSN: 15372898     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (20)
  • 1
    • 84934441932 scopus 로고    scopus 로고
    • Extended-release oral drug delivery technologies: Monolithic matrix systems
    • Jain KK, ed, Humana Press: Totowa, NJ;
    • Tiwari SB, Rajabi-Siahboomi AR. Extended-release oral drug delivery technologies: monolithic matrix systems. In: Jain KK, ed. Methods Mol Biol. Vol. 437. Humana Press: Totowa, NJ; 2008:217-243.
    • (2008) Methods Mol Biol , vol.437 , pp. 217-243
    • Tiwari, S.B.1    Rajabi-Siahboomi, A.R.2
  • 2
    • 0026621974 scopus 로고
    • Swelling characteristics of hydrophilic matrices for controlled release, new dimensionless number to describe the swelling and release behavior
    • Colombo P, Catellani PL, Peppas NA, Maggi L, Conte U. Swelling characteristics of hydrophilic matrices for controlled release, new dimensionless number to describe the swelling and release behavior. Int J Pharm. 1992;88:99-109.
    • (1992) Int J Pharm , vol.88 , pp. 99-109
    • Colombo, P.1    Catellani, P.L.2    Peppas, N.A.3    Maggi, L.4    Conte, U.5
  • 3
    • 52749091566 scopus 로고    scopus 로고
    • Modulation of drug release from hydrophilic matrices
    • September
    • Tiwari SB, Rajabi-Siahboomi AR. Modulation of drug release from hydrophilic matrices. Pharm Tech Eur. September 2008.
    • (2008) Pharm Tech Eur
    • Tiwari, S.B.1    Rajabi-Siahboomi, A.R.2
  • 5
    • 84889814085 scopus 로고    scopus 로고
    • Santos HMM, Sousa JJM. Tablet compression: In: Gad SC, ed. Pharmaceutical Manufacturing Handbook: Production and Processes. John Wiley & Sons: New York, NY; 2008:1133-1163.
    • Santos HMM, Sousa JJM. Tablet compression: In: Gad SC, ed. Pharmaceutical Manufacturing Handbook: Production and Processes. John Wiley & Sons: New York, NY; 2008:1133-1163.
  • 6
    • 77949673347 scopus 로고    scopus 로고
    • Pill identification tool. Website visited: http://www.webmd.com/ pillidentification/default.htm, Date accessed: August 28, 2009.
    • Pill identification tool. Website visited: http://www.webmd.com/ pillidentification/default.htm, Date accessed: August 28, 2009.
  • 7
    • 0036001091 scopus 로고    scopus 로고
    • Investigation of the effect of tablet surface area/volume on drug release from hydroxypropyl methylcellulose controlled-release matrix tablets
    • Reynolds TD, Mitchell SA, Balwinski KM. Investigation of the effect of tablet surface area/volume on drug release from hydroxypropyl methylcellulose controlled-release matrix tablets. Drug Dev Ind Pharm. 2004;28(4):457-466.
    • (2004) Drug Dev Ind Pharm , vol.28 , Issue.4 , pp. 457-466
    • Reynolds, T.D.1    Mitchell, S.A.2    Balwinski, K.M.3
  • 8
    • 0034713304 scopus 로고    scopus 로고
    • Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles
    • Siepmann J, Kranz H, Peppas NA, Bodmeier R. Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. Int J Pharm. 2000;201:151-164.
    • (2000) Int J Pharm , vol.201 , pp. 151-164
    • Siepmann, J.1    Kranz, H.2    Peppas, N.A.3    Bodmeier, R.4
  • 10
    • 77949757952 scopus 로고    scopus 로고
    • Caldwell LJ, Gardner CR, Cargill RC. Drug delivery device which can be retained in the stomach for a controlled period of time. US Patent No. 4735804. April 5, 1988.
    • Caldwell LJ, Gardner CR, Cargill RC. Drug delivery device which can be retained in the stomach for a controlled period of time. US Patent No. 4735804. April 5, 1988.
  • 11
    • 77949702202 scopus 로고    scopus 로고
    • Caldwell LJ, Gardner CR, Cargill RC, Higuchi T. Drug delivery device which can be retained in the stomach for a controlled period of time. US Patent No. 4758436. July 19, 1988.
    • Caldwell LJ, Gardner CR, Cargill RC, Higuchi T. Drug delivery device which can be retained in the stomach for a controlled period of time. US Patent No. 4758436. July 19, 1988.
  • 12
    • 77949758784 scopus 로고    scopus 로고
    • Curatolo WJ, Lo J. Gastric retention drug system for controlled drug release. US Patent No. 5443843. August 22, 1995.
    • Curatolo WJ, Lo J. Gastric retention drug system for controlled drug release. US Patent No. 5443843. August 22, 1995.
  • 13
    • 0037436034 scopus 로고    scopus 로고
    • Novel levodopa gastroretentive dosage form: In-vivo evaluation in dogs
    • Klausner EA, Eyal S, Lavy E, Friedman M, Hoffman, A. Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs. J Control Release. 2003;88 (1):117-126.
    • (2003) J Control Release , vol.88 , Issue.1 , pp. 117-126
    • Klausner, E.A.1    Eyal, S.2    Lavy, E.3    Friedman, M.4    Hoffman, A.5
  • 14
    • 42649110726 scopus 로고    scopus 로고
    • Influence of fillers, compression force, film coating and storage conditions on performance of hypromellose matrices
    • Levina M. Influence of fillers, compression force, film coating and storage conditions on performance of hypromellose matrices. Drug Del Tech. 2004;4(1):34-42.
    • (2004) Drug Del Tech , vol.4 , Issue.1 , pp. 34-42
    • Levina, M.1
  • 15
    • 77949751802 scopus 로고    scopus 로고
    • Palmer F, Levina M, Rajabi-Siahboomi AR. Investigation of a directly compressible metformin HCl 500 mg extended release formulation based on hypromellose. Paper presented at CRS Annual Meeting. June 18-22, 2005.
    • Palmer F, Levina M, Rajabi-Siahboomi AR. Investigation of a directly compressible metformin HCl 500 mg extended release formulation based on hypromellose. Paper presented at CRS Annual Meeting. June 18-22, 2005.
  • 16
    • 77949734953 scopus 로고    scopus 로고
    • Levina M, Palmer F, Rajabi-Siahboomi AR. Investigation of a directly compressible hypromellose matrix formulation for a low dose, practically insoluble drug. Paper presented at AAPS Annual Meeting and Exposition. November 6-10, 2005.
    • Levina M, Palmer F, Rajabi-Siahboomi AR. Investigation of a directly compressible hypromellose matrix formulation for a low dose, practically insoluble drug. Paper presented at AAPS Annual Meeting and Exposition. November 6-10, 2005.
  • 17
    • 2342652446 scopus 로고    scopus 로고
    • Mathematical comparison of curves with an emphasis on in vitro dissolution profiles
    • Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Tech. 1996;20(6):64-74.
    • (1996) Pharm Tech , vol.20 , Issue.6 , pp. 64-74
    • Moore, J.W.1    Flanner, H.H.2
  • 18
    • 0032948156 scopus 로고    scopus 로고
    • Influence of drug: Hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets
    • Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR. Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release. 1999;57:75-85.
    • (1999) J Control Release , vol.57 , pp. 75-85
    • Velasco, M.V.1    Ford, J.L.2    Rowe, P.3    Rajabi-Siahboomi, A.R.4
  • 19
    • 0035844738 scopus 로고    scopus 로고
    • Modelling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
    • Spiepmann J, Peppas NA. Modelling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139-157.
    • (2001) Adv Drug Deliv Rev , vol.48 , pp. 139-157
    • Spiepmann, J.1    Peppas, N.A.2
  • 20
    • 8644244579 scopus 로고    scopus 로고
    • The influence of excipients on drug release from hydroxypropyl methylcellulose matrices
    • Levina M, Rajabi-Siahboomi AR. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. Int J Pharm. 2004;93(11):2746-2754.
    • (2004) Int J Pharm , vol.93 , Issue.11 , pp. 2746-2754
    • Levina, M.1    Rajabi-Siahboomi, A.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.